Skip to main content
logo
Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
827.00
-21.00 (-2.48%)
At close: Feb 6, 2026

Nxera Pharma Revenue

Nxera Pharma had revenue of 6.75B JPY in the quarter ending September 30, 2025, a decrease of -27.09%. This brings the company's revenue in the last twelve months to 28.70B, down -1.96% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

Revenue (ttm)
28.70B
Revenue Growth
-1.96%
P/S Ratio
2.61
Revenue / Employee
74.74M
Employees
384
Market Cap
74.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.84B16.07B125.87%
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 20208.84B-884.00M-9.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Takara Bio44.08B
GNI Group25.78B
PeptiDream17.93B
RaQualia Pharma3.05B
Japan Tissue Engineering2.26B
AnGes818.00M
Cuorips360.00M
Healios K.K.97.00M
Revenue Rankings

Nxera Pharma News

More News